References
- Corey S J, Minden M D, Barber D L, Kantrjian H, Wang J CY, Schimmer A D. Myelodysplastic syndromes: the complexity of stem-cell diseases. Nat Rev Cancer 2007; 7: 118–129, Review
- Grosveld G C. MN1, a novel player in human AML. Blood Cells Mol Dis 2007; 39: 336–339, Review
- Buijs A, Sherr S, van Baal S, van Bezouw S, van der Plas D, Geurts van Kessel A, et al. Translocation (12;22) (p13;q11) in myeloproliferative disorders results in fusion of the ETS-like TEL gene on 12p13 to the MN1 gene on 22q11. Oncogene 1995; 10: 1511–1519
- Ross M E, Mahfouz R, Onciu M, Liu H C, Zhou X, Song G, et al. Gene expression profiling of pediatric acute myelogenous leukemia. Blood 2004; 104: 3679–3687
- Valk P J, Verhaak R G, Beijen M A, Erpelinck C A, Barjesteh van Waalwijk van Doorn-Khosrovani S, Boer J M, et al. Prognostically useful gene-expression profiles in acute myeloid leukemia. N Engl J Med 2004; 350: 1617–1628
- Liu P P, Hajra A, Wijmenga C, Collins F S. Molecular pathogenesis of the chromosome 16 inversion in the M4Eo subtype of acute myeloid leukemia. Blood 1995; 85: 2289–2302
- Du Y, Jenkins N A, Copeland N G. Insertional mutagenesis identifies genes that promote the immortalization of primary bone marrow progenitor cells. Blood 2005; 106: 3932–3939
- Heuser M, Beutel G, Krauter J, Döhner K, von Neuhoff N, Schlegelberger B, et al. High meningioma 1 (MN1) expression as a predictor for poor outcome in acute myeloid leukemia with normal cytogenetics. Blood 2006; 108: 3898–3905
- Heuser M, Argiropoulos B, Kuchenbauer F, Yung E, Piper J, Fung S, et al. MN1 overexpression induces acute myeloid leukemia in mice and predicts ATRA resistance in patients with AML. Blood 2007; 110: 1639–1647
- Steidl U, Bork S, Schaub S, Selbach O, Seres J, Aivado M, et al. Primary human CD34+ hematopoietic stem and progenitor cells express functionally active receptors of neuromediators. Blood 2004; 104: 81–88
- Carella C, Bonten J, Sirma S, Kranenburg T A, Terranova S, Klein-Geltink R, et al. MN1 overexpression is an important step in the development of inv(16) AML. Leukemia 2007; 21: 1679–1690